Abstract #2492

Rapid pre-biopsy MRI in patients with a clinical suspicion of prostate cancer: results of a controlled prospective registered IMPROD-trial

Ivan Jambor¹, Peter Boström², Pekka Taimen¹, Esa Kähkönen², Markku Kallajoki², Tommi Kauko¹, Ileana Montoya¹, Otto Ettala², Harri Merisaari¹, Kari Syvänen², and Hannu Juhani Aronen¹

¹University of Turku, Turku, Finland, ²Turku University Hospital, Turku, Finland

In this prospective single institution registered clinical trial we aimed to evaluate the role of rapid pre-biopsy prostate MRI consisting of T2-weighted imaging and DWI, no endorectal coil, no iv contrast. The primary end point was the diagnostic accuracy of the models incorporating clinical variables, PSA, and MRI findings. In total 175 patients were enrolled and 161 were included in final analyses. Rapid pre-biopsy prostate MRI was shown to be an accurate tool for the management of patients with a clinical suspicion of prostate cancer.

This abstract and the presentation materials are available to members only; a login is required.

Join Here